P171 - A prospective real life study evaluating abiraterone Acetate Plus Prednisone (AAP) for Metastatic Castration Resistant Prostate Cancer (mCRPC) (Abitude Study).

Authors :: Sciarra, A.
Scarcia, M.
Cindolo, L.
Verze, P.
Salciccia, S.
Ludovico, G.
Castellan, P.
Battaglia, M.
Carrieri, G.
Cicalese, V.
De Lisa, A.
Uricchio, F.
Livi, L.
Santini, D.
Procopio, G.
Beccaglia, P.
Gallucci, M.
Mirone, V.
Source :: European Urology Supplements. Sep2018, Vol. 17 Issue 8, p277-277. 1p.
Publication Year :: 2018

Subjects :: *PREDNISONE
*PROSTATE cancer patients
*CANCER chemotherapy
*COHORT analysis
*PAIN measurement

Full Text Access

Tools